About
PROMEDIUS is a Korean medical technology company founded in 2019, specializing in AI-driven solutions for healthy aging. The company focuses on early detection and management of age-related musculoskeletal and metabolic diseases, aiming to redefine aging as an opportunity for healthy longevity. The company develops advanced diagnostic tools, including Osteo Signal (PROS® CXR: OSTEO), an AI software that analyzes chest X-rays to detect osteoporosis early. Another product, PROS® CT: MQ, also utilizes AI for medical imaging analysis. Additionally, PROMEDIUS offers AIdant, a cloud-native platform that connects healthcare professionals with AI diagnostic tools for various conditions, enhancing medical image analysis and parameter measurements. PROMEDIUS has established collaborations with notable institutions and has received multiple patents for its innovations. The company targets healthcare providers and diagnostic centers globally, with a commitment to improving access to advanced diagnostic AI, particularly in regions with limited radiology resources.
Technologies
Keywords
Company Information
-
Employees 21
-
Founded 2019
Location
Seoul, South Korea, 05510